Publications by authors named "Ricardo C Rotter"
Background: Excess aldosterone accelerates chronic kidney disease progression. This phase 2 clinical trial assessed BI 690517, an aldosterone synthase inhibitor, for efficacy, safety, and dose selection.
Methods: This was a multinational, randomised, controlled, phase 2 trial.
Article Synopsis
- The International Society of Nephrology is addressing gaps in kidney care through a proactive initiative aimed at managing acute kidney injury and chronic kidney disease (CKD).
- A working group identified three main goals to enhance CKD management: optimize treatment for anemia and metabolic issues, improve prevention and management of cardiovascular complications, and better diagnose and manage CKD-related symptoms.
- This initiative acknowledges the global impact of CKD, especially in regions lacking sufficient renal replacement therapy, and aims to improve patient outcomes by addressing these critical areas.
Objectives: The aims of this study were to identify the possible association of osteoporosis, fracture risk and periodontitis, and consider the role of pharmacological treatment of osteoporosis and the periodontal condition.
Methods: Patients aged 60 and older from the Mexican National Medical Science and Nutrition Institute Salvador Zubirán participated in the study. DXA was used to assess osteoporosis and risk of vertebral fracture.